ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 6, June 2025 | pp. 144–154
DOI: 10.46882/AJIDR/148794
Article Type: Review Article
Title: Antimicrobial resistance trends, virulence mechanisms, and therapeutic options for invasive non-typhoidal Salmonella infections
Names of Authors: Kwame Osei-Tutu¹*, Freja Lindholm², Ananya Sharma³
Authors’ Affiliations: ¹Department of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. ²Department of Clinical Microbiology, University of Copenhagen, Copenhagen, Denmark. ³Department of Infectious Diseases, All India Institute of Medical Sciences, New Delhi, India.
Abstract: Invasive non-typhoidal Salmonella is a leading cause of fatal bloodstream infections among young children with severe malaria or malnutrition and immunocompromised adults. We synthesized genomic surveillance data, clinical cohort outcomes, and antibiotic susceptibility reports across sub-Saharan Africa. Peer-reviewed studies published over the past decade were systematically reviewed. Multidrug-resistant Salmonella Typhimurium sequence type 313 predominates across the region, exhibiting widespread resistance to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole, alongside emerging fluoroquinolone non-susceptibility. Accelerating multivalent vaccine development and strengthening blood culture diagnostics are vital to reduce mortality.
Keywords: Non-typhoidal Salmonella, Bloodstream infection, Antimicrobial resistance, Sequence type 313, Invasive bacterial disease
Citation: Osei-Tutu K, Lindholm F, Sharma A (2025). Antimicrobial resistance trends, virulence mechanisms, and therapeutic options for invasive non-typhoidal Salmonella infections. African Journal of Infectious Diseases Research, 12(6): 144–154. DOI: 10.46882/AJIDR/148794
Manuscript Timeline: Received: April 21, 2025; Revised: May 24, 2025; Accepted: June 07, 2025; Published: June 14, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read